People with rapid eye movement (REM) sleep behavior disorder act out their dreams. While sleeping safely in bed, for example, they might throw up their
Researchers at Washington University School of Medicine, the Mayo Clinic in Rochester, Minn., and The Neuro of McGill University have received a five-year grant expected to total $35.1 million for an extension of a study designed to develop biomarkers that indicate which people with REM sleep behavior disorder will go on to develop neurodegenerative diseases.
People with rapid eye movement (REM) sleep behavior disorder act out their dreams. While sleeping safely in bed, for example, they might throw up their arms to catch an imaginary ball, or try to run from an illusory assailant.
Researchers identify potential new treatment targets for Alzheimer s disease
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer s disease, as well as existing drugs that have therapeutic potential against these targets.
The potential targets are defective proteins that lead to the buildup of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer s. The 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers.
Study identifies potential new treatment targets for Alzheimer s disease ANI | Updated: Jul 09, 2021 08:56 IST
Washington [US], July 9 (ANI): Potential new treatment targets for Alzheimer s disease, as well as existing drugs that have therapeutic potential against these targets, have been identified by a research team at Washington University School of Medicine in St Louis.
The new study, funded by the National Institute on Aging of the National Institutes of Health (NIH), was published in the journal Nature Neuroscience.
The potential targets are defective proteins that lead to the build-up of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer s.